The Academy of Managed Care Pharmacy is spearheading a renewed push for federal policies allowing biopharmaceutical manufacturers to share off-label economic data on drugs with formulary managers and is also urging a more expansive view of what that data can include.
Rx Economic Information-Sharing Concept Getting Renewed Push
Payers join biopharma in seeking clarity around information-sharing provisions in FDAMA Sec. 114 – and in expanding the kind of off-label data that could be disseminated under the law.